Tempus extends data licensing partnership with Recursion through November 2029
Bitget2026/09/21 16:17- Tempus extended its multi-year data license partnership with Recursion through November 2029.
- Deal resets original master agreement fees to committed payments totaling $42 million over three years.
- Prior structure included discretionary license fees potentially totaling $84 million over the next two years.
- Separate agreement grants a non-exclusive, worldwide license to Recursion’s RNA foundation model, TxFM.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Rising energy prices increase inflation risks, Reserve Bank of Australia expected to implement the fourth rate hike of the year next week
As rising energy prices further highlight upward inflation risks, economists state that the Reserve Bank of Australia will raise its key interest rate next week and warn that there could be another hike in November.
Ark Invest increased its holdings of Meta Platforms shares by approximately 38.15 million dollars yesterday.
British Pound consolidates vs USD; bearish bias remains amid divergent Fed-BoE outlook

AI pharmaceutical company Iambic (IAM.US), supported by Nvidia, applies for US IPO to advance three early-stage cancer drugs
Iambic Therapeutics Inc. has filed for an initial public offering (IPO) in the United States.